A simultaneous assay of the differentiating agents, phenylacetic acid and phenylbutyric acid, and one of their metabolites, phenylacetyl-glutamine, by reversed-phase, high performance liquid chromatography

Journal of Liquid Chromatography

Volumn 17, Issue 13, 1994, Pages 2895-2900

  Thibault, Alain ^a   Figg, William D ^a   McCall, Natalie ^a   Samid, Dvorit ^a   Myers, Charles E ^a   Cooper, Michael R ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETONITRILE; ADDITION REACTIONS; AGENTS; AMINES; ASSAYS; CARBOXYLIC ACIDS; EXTRACTION; IONIZATION; LIGHT ABSORPTION; METABOLITES; PRECIPITATION (CHEMICAL); ULTRAVIOLET RADIATION;

DIFFERENTIATING AGENTS; NEUTRALIZATION; PERCHLORIC ACID; PHENYLACETIC ACID; PHENYLACETYLGLUTAMINE; PHENYLBUTYRIC ACID;

HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

ARYLBUTYRIC ACID DERIVATIVE; PHENYLACETIC ACID;

ARTICLE; CHEMICAL STRUCTURE; IONIZATION; NONHUMAN; PROTEIN PURIFICATION; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ULTRAVIOLET SPECTROSCOPY;

EID: 0028484585     PISSN: 01483919     EISSN: None     Source Type: Journal    
DOI: 10.1080/10826079408013507     Document Type: Article

References (13)

1. D. Samid, S. Shack, and L.T. Sherman. Phenylacetate: a novel nontoxic inducer of tumor cell differentiation. Cancer Res., 2: 1988–1992 (1992).
2. S.W. Brusilow, M. Danney, L.J. Waber, M. Batshaw, B. Burton, L. Levitzky, K. Roth, C. McKeethren, and J. Ward. Treatment of episodic hyperammonemia in children with inborn errors of urea synthesis. N. Engl. J. Med., 3JJQ: 1630–1634 (1984).
3. O. Simell, I. Sipila, J. Rajantie, D.L. Valle, and S.W. Brusilow. Waste nitrogen excretion via amino acid acylation: benzoate and phenylacetate in lysinuric protein intolerance. Pediatr. Res., 20: 1117–1121 (1986).
4. A.J. Watson, J.E. Karp, W.G. Walker, T. Chambers, V.R. Risch, and S.W. Brusilow. Transient idiopathic hyperammonemia in adults. Lancet, n: 1271–1274 (1985).
5. C.L. Mendenhall, S. Rouster, L. Marshall, R.A. Weesner. A new therapy for portal systemic encephalopathy. Am. J. Gastroenterol., 1: 540–543 (1986).
6. M.O. James, R.L. Smith, F.R.S. Williams, and M. Reidenberg. The conjugation of phenylacetic acid in man, sub-human primates and some non-primate species. Proc. R. Soc. Lond.B., 2: 25–35 (1972).
7. D. Samid, A. Yeh, and P. Prasana. Induction of erythroid differentiation and fetal hemoglobin production in human leukemic cells treated with phenylacetate. Blood, 7: 1576–1581 (1992).
8. G.J. Dover, S. Brusilow, and D. Samid. Increased fetal hemoglobin in patients receiving sodium 4-phenylbutyrate. N. Engl. J. Med., 222: 569–570 (1992).
9. D. Samid, S. Shack, and C.E. Myers. Selective growth arrest and phenotypic reversion of prostate cancer cells in vitro by nontoxic pharmacological concentrations of phenylacetate. J. Clin. Invest., 21: 2288–2295 (1993).
10. S.W. Brusilow. Phenylacetylglutamine may replace urea as a vehicle for waste nitrogen excretion. Pediatr. Res., 22: 147–150 (1991).
11. W.H. Stein. A chromatographic investigation of the amino acid constituents of normal urine. J. Biol. Chem. 2QT1 45–47 (1953).
12. M. Sandler, C.R.J. Ruthven, B.L. Goodwin, A. Lees, and G.M. Stern. Phenylacetic acid in human body fluids: high correlation between plasma and cerebrospinal fluid concentrations values. J. Neurol. Neurosurg. Psych. 4: 366–368 (1982).
13. M.E. Martin, F. Karoum, and R.J. Wyatt. Phenylacetic acid excretion in man. Analyt. Chem. 22: 283–287 (1979).